目的探讨一步法多重RT-PCR对儿童急性淋巴细胞白血病(ALL)常见4种融合基因的检测效果。方法 2003年1月至2010年12月确诊的ALL患儿76例,采集所有患儿骨髓标本,提取细胞总RNA,一步法多重RT-PCR或常规巢式PCR法对E2A/PBX1、MLL/AF4、BCR/AB...目的探讨一步法多重RT-PCR对儿童急性淋巴细胞白血病(ALL)常见4种融合基因的检测效果。方法 2003年1月至2010年12月确诊的ALL患儿76例,采集所有患儿骨髓标本,提取细胞总RNA,一步法多重RT-PCR或常规巢式PCR法对E2A/PBX1、MLL/AF4、BCR/ABL和TEL/AML1融合基因进行检测;DNA测序对PCR结果进行验证。结果一步法多重RT-PCR及DNA测序验证显示76例ALL患儿中,TEL/AML1融合基因阳性12例(产物长度分别为298 bp 9例,259 bp 3例),E2A/PBX1融合基因阳性3例(产物长度373 bp),BCR/ABL融合基因阳性1例(产物长度2124 bp),MLL/AF4融合基因阳性7例(产物长度分别为427 bp 1例,673 bp 6例),与常规巢式PCR检出结果一致。结论一步法多重RT-PCR可应用于儿童ALL常见融合基因的检测。展开更多
Hepatitis B virus(HBV),one of the well-known DNA oncogenic viruses,is the leading cause of hepatocellular carcinoma(HCC).In infected hepatocytes,HBV DNA can be integrated into the host genome through an insertional mu...Hepatitis B virus(HBV),one of the well-known DNA oncogenic viruses,is the leading cause of hepatocellular carcinoma(HCC).In infected hepatocytes,HBV DNA can be integrated into the host genome through an insertional mutagenesis process inducing tumorigenesis.Dissection of the genomic features surrounding integration sites will deepen our understanding of mechanisms underlying integration.Moreover,the quantity and biological activity of integration sites may reflect the DNA damage within affected cells or the potential survival benefits they may confer.The wellknown human genomic features include repeat elements,particular regions(such as telomeres),and frequently interrupted genes(e.g.,telomerase reverse transcriptase[i.e.TERT],lysine methyltransferase 2B[i.e.KMT2B],cyclin E1[CCNE1],and cyclin A2[CCNA2]).Consequently,distinct genomic features within diverse integrations differentiate their biological functions.Meanwhile,accumulating evidence has shown that viral proteins produced by integrants may cause cell damage even after the suppression of HBV replication.The integration-derived gene products can also serve as tumor markers,promoting the development of novel therapeutic strategies for HCC.Viral integrants can be single copy or multiple copies of different fragments with complicated rearrangement,which warrants elucidation of the whole viral integrant arrangement in future studies.All of these considerations underlie an urgent need to develop novel methodology and technology for sequence characterization and function evaluation of integration events in chronic hepatitis B-associated disease progression by monitoring both host genomic features and viral integrants.This endeavor may also serve as a promising solution for evaluating the risk of tumorigenesis and as a companion diagnostic for designing therapeutic strategies targeting integration-related disease complications.展开更多
Chromosomal translocation leads to the juxtaposition of two otherwise separate DNA loci,which could result in gene fusion.These rearrangements at the DNA level are catastrophic events and often have causal roles in tu...Chromosomal translocation leads to the juxtaposition of two otherwise separate DNA loci,which could result in gene fusion.These rearrangements at the DNA level are catastrophic events and often have causal roles in tumorigenesis.The oncogenic DNA messages are transferred to RNA molecules,which are in most cases translated into cancerous fusion proteins.Gene expression programs and signaling pathways are altered in these cytogenetically abnormal contexts.Notably,non-toding RNAs have attracted increasing attention and are believed to be tightly associated with chromosome-rearranged cancers.These RNAs not only function as modulators in downstream pathways but also directly affect chromosomal translocation or the associated products.This review summarizes recent research advances on the relationship between non-coding RNAs and chromosomal translocations and on diverse functions of non-coding RNAs in cancers with chromosomal rearrangements.展开更多
Importance: By demonstrating with TEL-AML1, this study indicated that mRNAs transcribed from fusion genes are ideal targets for minimal residual disease (MRD) monitoring in childhood acute lymphoblastic leukemia, and ...Importance: By demonstrating with TEL-AML1, this study indicated that mRNAs transcribed from fusion genes are ideal targets for minimal residual disease (MRD) monitoring in childhood acute lymphoblastic leukemia, and that different thresholds are needed to apply them into the risk stratification. Objective: TEL-AML1 expression was measured at three time points to 1) determine cut-off values for predicting acute lymphoblastic leukemia (ALL) relapse;2) investigate the prognostic value of this method and how well the results at these time points correlated;3) determine the correlation between MRD levels assessed using this marker and that determined by immunoglobulin/T-cell receptor (Ig/TCR) rearrangement detection. Methods: TEL-AML1 expression in 62 children with ALL was quantitated by real-time quantitative PCR at day 15, day 33, and month 3. The relationship between patient outcome and TEL-AML1 level was analyzed at each time point. The correlation between the MRD levels determined by TEL-AML1 or Ig/TCR rearrangements was also analyzed. results: For day 33, 6.68 TEL-AML1 copies/104 ABL copies was determined to be the best cut-off value. Higher levels were correlated with relapse (P = 0.001). For day 15 and month 3, the best cut-off values were 336.5 and 0.85 copies/104 ABL copies respectively;patients with higher expression levels had lower RFSs (day 15: P = 0.027;month 3:P = 0.023). For days 15 and 33, MRD levels assessed using TEL-AML1 or Ig/TCR rearrangements were strongly correlated [Spearman rank correlation coefficient (ρ) = 0.729 (day 15), 0.719 (day 33);P < 0.001 (both)], and both methods were equally effective at predicting relapse. At month 3, there was moderate correlation between the results derived from the two markers (ρ = 0.418, P = 0.003);however, receiver operating characteristic curve analysis showed that TEL-AML1 was a better prognostic marker. Interpretation: TEL-AML1 is an effective marker for MRD assessment and relapse prediction in children with ALL.展开更多
Objectives: To define the involvement of CALM and AF10 fusion transcripts in primary leukaemias with t(10; 11). Methods: The AF10 and CALM fusion in five t(10; 11) leukemia samples were checked by reverse transcriptas...Objectives: To define the involvement of CALM and AF10 fusion transcripts in primary leukaemias with t(10; 11). Methods: The AF10 and CALM fusion in five t(10; 11) leukemia samples were checked by reverse transcriptase-polymerase chain reaction (RT-PCR), and effects of CALM/AF10 antisense phosphorothioate oligodeoxynucleotides (AS PS-ODNs) on chemotherapy sensitivity and apoptosis of leukemia cells in vitro were observed. Results: Five different-sized AF10-CALM products and four different-sized CALM/AF10 products were detected by RT-PCR. The chemotherapy sensitivity of leukemic cells with t(10; 11) to drugs in vitro was lower than that of leukemic cells without t(10; 11). AS PS-ODNs increased the chemotherapy sensitivity and apoptotic rate. There were 4 cases positive at 5 μmol/L concentration, all cases positive at 10 μmol/L and 20 μmol/L concentration, P<0.01 vs only chemotherapeutic drugs (3 cases positive), and chemotherapeutic drugs + S-PS-ODNs (10 μmol/L) (3 cases positive). After cells were treated with 10 μmol/L AS-PS-ODNs + chemotherapeutic drugs for 48 h, 72 h, 96 h, the apoptotic indexes were 14.22±2.86, 29.39±3.57, and 41.26±4.52, respectively. These were significantly higher than those of only chemotherapeutic drugs-treated cells and chemotherapeutic drugs + S-PS-ODNs-treated cells at corresponding time (P<0.01). There was no difference between only drugs group and S-PS-ODNs group at corresponding time (P>0.05). Conclusion: The CALM and AF10 fusion transcripts are involved in the pathogenesis of haematological malignancies with t(10, 11), and is associated with a poor prognosis. AS-PS-ODNs might be useful in therapy of t(10, 11) leukemia. Key words AF10 - CALM - Fusion transcript - Primary leukemia cell - In vitro sensitivity - Antisense oligodeoxynucleotide CLC number R733.7 Biography: LIU Ge-xiu (1968–), male, associate professor, Institute of Hematology, Medical College, Jinan University, majors in hematology.展开更多
文摘目的探讨一步法多重RT-PCR对儿童急性淋巴细胞白血病(ALL)常见4种融合基因的检测效果。方法 2003年1月至2010年12月确诊的ALL患儿76例,采集所有患儿骨髓标本,提取细胞总RNA,一步法多重RT-PCR或常规巢式PCR法对E2A/PBX1、MLL/AF4、BCR/ABL和TEL/AML1融合基因进行检测;DNA测序对PCR结果进行验证。结果一步法多重RT-PCR及DNA测序验证显示76例ALL患儿中,TEL/AML1融合基因阳性12例(产物长度分别为298 bp 9例,259 bp 3例),E2A/PBX1融合基因阳性3例(产物长度373 bp),BCR/ABL融合基因阳性1例(产物长度2124 bp),MLL/AF4融合基因阳性7例(产物长度分别为427 bp 1例,673 bp 6例),与常规巢式PCR检出结果一致。结论一步法多重RT-PCR可应用于儿童ALL常见融合基因的检测。
基金This work was supported by the 111Project(Project No.:B13003)Innovation Promotion Association CAS(2016098)National Natural Science Foundation of China(81201700)to D.Z。
文摘Hepatitis B virus(HBV),one of the well-known DNA oncogenic viruses,is the leading cause of hepatocellular carcinoma(HCC).In infected hepatocytes,HBV DNA can be integrated into the host genome through an insertional mutagenesis process inducing tumorigenesis.Dissection of the genomic features surrounding integration sites will deepen our understanding of mechanisms underlying integration.Moreover,the quantity and biological activity of integration sites may reflect the DNA damage within affected cells or the potential survival benefits they may confer.The wellknown human genomic features include repeat elements,particular regions(such as telomeres),and frequently interrupted genes(e.g.,telomerase reverse transcriptase[i.e.TERT],lysine methyltransferase 2B[i.e.KMT2B],cyclin E1[CCNE1],and cyclin A2[CCNA2]).Consequently,distinct genomic features within diverse integrations differentiate their biological functions.Meanwhile,accumulating evidence has shown that viral proteins produced by integrants may cause cell damage even after the suppression of HBV replication.The integration-derived gene products can also serve as tumor markers,promoting the development of novel therapeutic strategies for HCC.Viral integrants can be single copy or multiple copies of different fragments with complicated rearrangement,which warrants elucidation of the whole viral integrant arrangement in future studies.All of these considerations underlie an urgent need to develop novel methodology and technology for sequence characterization and function evaluation of integration events in chronic hepatitis B-associated disease progression by monitoring both host genomic features and viral integrants.This endeavor may also serve as a promising solution for evaluating the risk of tumorigenesis and as a companion diagnostic for designing therapeutic strategies targeting integration-related disease complications.
基金This research was supported by the National Key R&D Program of China(2017YFA0504400)the National Natural Science Foundation of China(81770174 and 31870818).
文摘Chromosomal translocation leads to the juxtaposition of two otherwise separate DNA loci,which could result in gene fusion.These rearrangements at the DNA level are catastrophic events and often have causal roles in tumorigenesis.The oncogenic DNA messages are transferred to RNA molecules,which are in most cases translated into cancerous fusion proteins.Gene expression programs and signaling pathways are altered in these cytogenetically abnormal contexts.Notably,non-toding RNAs have attracted increasing attention and are believed to be tightly associated with chromosome-rearranged cancers.These RNAs not only function as modulators in downstream pathways but also directly affect chromosomal translocation or the associated products.This review summarizes recent research advances on the relationship between non-coding RNAs and chromosomal translocations and on diverse functions of non-coding RNAs in cancers with chromosomal rearrangements.
文摘Importance: By demonstrating with TEL-AML1, this study indicated that mRNAs transcribed from fusion genes are ideal targets for minimal residual disease (MRD) monitoring in childhood acute lymphoblastic leukemia, and that different thresholds are needed to apply them into the risk stratification. Objective: TEL-AML1 expression was measured at three time points to 1) determine cut-off values for predicting acute lymphoblastic leukemia (ALL) relapse;2) investigate the prognostic value of this method and how well the results at these time points correlated;3) determine the correlation between MRD levels assessed using this marker and that determined by immunoglobulin/T-cell receptor (Ig/TCR) rearrangement detection. Methods: TEL-AML1 expression in 62 children with ALL was quantitated by real-time quantitative PCR at day 15, day 33, and month 3. The relationship between patient outcome and TEL-AML1 level was analyzed at each time point. The correlation between the MRD levels determined by TEL-AML1 or Ig/TCR rearrangements was also analyzed. results: For day 33, 6.68 TEL-AML1 copies/104 ABL copies was determined to be the best cut-off value. Higher levels were correlated with relapse (P = 0.001). For day 15 and month 3, the best cut-off values were 336.5 and 0.85 copies/104 ABL copies respectively;patients with higher expression levels had lower RFSs (day 15: P = 0.027;month 3:P = 0.023). For days 15 and 33, MRD levels assessed using TEL-AML1 or Ig/TCR rearrangements were strongly correlated [Spearman rank correlation coefficient (ρ) = 0.729 (day 15), 0.719 (day 33);P < 0.001 (both)], and both methods were equally effective at predicting relapse. At month 3, there was moderate correlation between the results derived from the two markers (ρ = 0.418, P = 0.003);however, receiver operating characteristic curve analysis showed that TEL-AML1 was a better prognostic marker. Interpretation: TEL-AML1 is an effective marker for MRD assessment and relapse prediction in children with ALL.
文摘Objectives: To define the involvement of CALM and AF10 fusion transcripts in primary leukaemias with t(10; 11). Methods: The AF10 and CALM fusion in five t(10; 11) leukemia samples were checked by reverse transcriptase-polymerase chain reaction (RT-PCR), and effects of CALM/AF10 antisense phosphorothioate oligodeoxynucleotides (AS PS-ODNs) on chemotherapy sensitivity and apoptosis of leukemia cells in vitro were observed. Results: Five different-sized AF10-CALM products and four different-sized CALM/AF10 products were detected by RT-PCR. The chemotherapy sensitivity of leukemic cells with t(10; 11) to drugs in vitro was lower than that of leukemic cells without t(10; 11). AS PS-ODNs increased the chemotherapy sensitivity and apoptotic rate. There were 4 cases positive at 5 μmol/L concentration, all cases positive at 10 μmol/L and 20 μmol/L concentration, P<0.01 vs only chemotherapeutic drugs (3 cases positive), and chemotherapeutic drugs + S-PS-ODNs (10 μmol/L) (3 cases positive). After cells were treated with 10 μmol/L AS-PS-ODNs + chemotherapeutic drugs for 48 h, 72 h, 96 h, the apoptotic indexes were 14.22±2.86, 29.39±3.57, and 41.26±4.52, respectively. These were significantly higher than those of only chemotherapeutic drugs-treated cells and chemotherapeutic drugs + S-PS-ODNs-treated cells at corresponding time (P<0.01). There was no difference between only drugs group and S-PS-ODNs group at corresponding time (P>0.05). Conclusion: The CALM and AF10 fusion transcripts are involved in the pathogenesis of haematological malignancies with t(10, 11), and is associated with a poor prognosis. AS-PS-ODNs might be useful in therapy of t(10, 11) leukemia. Key words AF10 - CALM - Fusion transcript - Primary leukemia cell - In vitro sensitivity - Antisense oligodeoxynucleotide CLC number R733.7 Biography: LIU Ge-xiu (1968–), male, associate professor, Institute of Hematology, Medical College, Jinan University, majors in hematology.
